Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Science Translational Medicine

• Publication date

  2017-06-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/scitranslmed.aal2094PMID 28592561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Germinal Centers

  2017cited by this paper
• Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

  2016cited by this paper
• Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination

  2016cited by this paper
• Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines

  2016cited by this paper
• Local innate immune responses in the vaccine adjuvant-injected muscle

  2016cited by this paper
• Analysis of immunoglobulin transcripts and hypermutation following SHIVAD8 infection and protein-plus-adjuvant immunization

  2015cited by this paper
• Human Anti-CD40 Antibody and Poly IC:LC Adjuvant Combination Induces Potent T Cell Responses in the Lung of Nonhuman Primates

  2015cited by this paper
• Oil-in-Water Emulsion MF59 Increases Germinal Center B Cell Differentiation and Persistence in Response to Vaccination

  2015cited by this paper
• Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus

  2015cited by this paper
• Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques.

  2015cited by this paper
• MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life

  2015cited by this paper
• Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma

  2015cited by this paper
• Rational design of small molecules as vaccine adjuvants

  2014cited by this paper
• Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells

  2014cited by this paper
• Neutrophils control the magnitude and spread of the immune response in a thromboxane A2-mediated process

  2013cited by this paper
• Dendritic cell recruitment in response to skin antigen tests in HIV-1-infected individuals correlates with the level of T-cell infiltration

  2013cited by this paper
• The B cell helper side of neutrophils

  2013cited by this paper
• Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells

  2013cited by this paper
• Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype.

  2013cited by this paper
• Coadministration of Polyinosinic:Polycytidylic Acid and Immunostimulatory Complexes Modifies Antigen Processing in Dendritic Cell Subsets and Enhances HIV Gag-Specific T Cell Immunity

  2013cited by this paper
• CD4 T follicular helper cell dynamics during SIV infection.

  2012cited by this paper
• The mechanism of action of MF59 - an innately attractive adjuvant formulation.

  2012cited by this paper
• Germinal centers.

  2012cited by this paper
• Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro

  2012cited by this paper
• Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial.

  2011cited by this paper
• Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation.

  2011cited by this paper
• MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines

  2011cited by this paper
• Human and rhesus plasmacytoid dendritic cell and B‐cell responses to Toll‐like receptor stimulation

  2011cited by this paper
• Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes.

  2011influential reference
• Programming the magnitude and persistence of antibody responses with innate immunity

  2010cited by this paper
• Vaccine adjuvants: putting innate immunity to work.

  2010influential reference
• Toll-Like Receptor 3 Ligand and Retinoic Acid Enhance Germinal Center Formation and Increase the Tetanus Toxoid Vaccine Response

  2009cited by this paper
• Molecular and cellular signatures of human vaccine adjuvants

  2008cited by this paper
• Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

  2008cited by this paper
• Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates.

  2008cited by this paper
• Murine neutrophils present Class II restricted antigen

  2008cited by this paper
• Neutrophils efficiently cross-prime naive T cells in vivo.

  2007cited by this paper
• Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

  2007cited by this paper
• Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates

  2006cited by this paper
• Cutting Edge: Enhancement of Antibody Responses Through Direct Stimulation of B and T Cells by Type I IFN1

  2006cited by this paper
• Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses

  2003cited by this paper
• Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses 1

  2003cited by this paper
• Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice.

  1999cited by this paper
• Activation of human T cells by major histocompatability complex class II expressing neutrophils: proliferation in the presence of superantigen, but not tetanus toxoid.

  1997cited by this paper

• Intranasal unadjuvanted LcrV boosts parental Yersinia OMV primed lung immunity against pneumonic plague in mice

  2026cites this paper
• Biomimetic vesicles engineered from modified tumour cells act as personalized vaccines for post-surgical cancer immunotherapy.

  2026cites this paper
• Hyaluronic acid–based dissolving microneedles regulate antigen release and route-dependent immunogenicity of adenovirus-based vaccines

  2026cites this paper
• COVID-19 vaccine type controls stromal reprogramming in draining lymph nodes.

  2025cites this paper
• Linking vaccine adjuvant mechanisms of action to function.

  2025cites this paper
• A novel ionizable lipid with comprehensive improvements in transfection potency, immune profile and safety of lipid nanoparticle.

  2025cites this paper
• Shaping Antitumor Immunity with Peptide Vaccines: Implications of Immune Modulation at the Vaccine Site

  2025cites this paper
• Neutrophils in Type 1 Diabetes: Untangling the Intricate Web of Pathways and Hypothesis

  2025cites this paper
• Photoimmunological hydrogel vaccine creates a supportive immune niche to promote antigen cross-presentation cascade and cancer-immunity cycle progression

  2025cites this paper
• Current Status and Potential of Immune Adjuvants in Mycotoxin Immune Enhancement: Mechanisms, Innovations, and Applications.

  2025cites this paper
• Early lymph node T follicular helper cell signalling hub drives influenza vaccine response in an ancestrally diverse cohort

  2025cites this paper
• Distinct effects of adjuvants on B cell responses to protein or polysaccharide antigens contained in glycoconjugate vaccines

  2025cites this paper
• Polysaccharide Adjuvants as Innate Immune Trainers: Bridging Pattern Recognition Receptor (PRR) Activation and Metabolic Reprogramming for Synthetic Vaccine Design

  2025cites this paper
• Early spatiotemporal evolution of the immune response elicited by adenovirus serotype 26 vector vaccination in mice

  2025cites this paper
• Accelerating Vaccine Adjuvant Screening: Early Follicular Dendritic Cell and Germinal Center B Cell Biomarkers Predict Protective Efficacy

  2025cites this paper
• Transcriptional Systems Vaccinology Approaches for Vaccine Adjuvant Profiling

  2025cites this paper
• Role of T Follicular Helper Cells in Viral Infections and Vaccine Design

  2025cites this paper
• Alpha hemolysin enhances the immune response by modulating dendritic cell differentiation via ADAM10-Notch signaling

  2025cites this paper
• Advanced technologies for the development of infectious disease vaccines

  2024cites this paper
• Chronological Management of Adjuvant Effect for Optimized mRNA Vaccine Inspired by Natural Virus Infection.

  2024cites this paper
• Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response

  2024cites this paper
• Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

  2024cites this paper
• Boosting the immune response in COVID-19 vaccines via an Alum:CpG complex adjuvant.

  2024cites this paper
• Early spatiotemporal evolution of the immune response elicited by adenovirus serotype 26 vector vaccination in mice

  2024cites this paper
• Controlling the speed of antigens transport in dendritic cells improves humoral and cellular immunity for vaccine.

  2024cites this paper
• Vaccine adjuvants: Tailoring innate recognition to send the right message.

  2024cites this paper
• Stepwise Ultra-pH-Sensitive Micelles Overcome a pKa Barrier for Systemic Lymph Node Delivery.

  2024cites this paper
• Lymph node-targeted STING agonist nanovaccine against chronic HBV infection

  2024cites this paper
• Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2

  2024cites this paper
• Human in vitro modeling identifies adjuvant combinations that unlock antigen cross-presentation and promote T-helper 1 development in newborns, adults and elders.

  2024cites this paper
• Lymphatic distribution considerations for subunit vaccine design and development.

  2024cites this paper
• Early regional lymph node activation drives influenza vaccine responses in an ancestrally diverse cohort

  2024cites this paper
• Innate immune cell activation by adjuvant AS01 in human lymph node explants is age independent

  2024cites this paper
• mRNA vaccine boosters and impaired immune system response in immune compromised individuals: a narrative review

  2024cites this paper
• Generation of antigen-specific memory CD4 T cells by heterologous immunization enhances the magnitude of the germinal center response upon influenza infection

  2024cites this paper
• Modulating Antigen Availability in Lymphoid Organs to Shape the Humoral Immune Response to Vaccines.

  2024cites this paper
• Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis

  2024cites this paper
• The scientific journey of a novel adjuvant (AS37) from bench to bedside

  2024cites this paper
• Biodistribution and mechanisms of action of MF59 and MF59-like adjuvants.

  2024cites this paper
• Unveiling signaling pathways inducing MHC class II expression in neutrophils

  2024cites this paper
• Prophylactic and therapeutic vaccine development: advancements and challenges

  2024cites this paper
• Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children

  2023cites this paper
• Neutrophils Are Atypical Antigen-Presenting Cells

  2023cites this paper
• Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses.

  2023cites this paper
• Effective Pre-Clinical Treatment of Fish Envenoming with Polyclonal Antiserum

  2023cites this paper
• Fusion of the molecular adjuvant C3d to cleavage-independent native-like HIV-1 Env trimers improves the elicited antibody response

  2023cites this paper
• A liposomal vaccine promotes strong adaptive immune responses via dendritic cell activation in draining lymph nodes.

  2023cites this paper
• Virus-like Magnetic Mesoporous Silica Particles as a Universal Vaccination Platform against Pathogenic Infections.

  2023cites this paper
• Progress in vaccine development for infectious diseases—a Keystone Symposia report

  2023cites this paper
• Evaluation of Aluminium Hydroxide Nanoparticles as an Efficient Adjuvant to Potentiate the Immune Response against Clostridium botulinum Serotypes C and D Toxoid Vaccines

  2023cites this paper
• Antigen-caged-adjuvant nanovaccines elicit potent humoral and cellular immune responses

  2023cites this paper
• Considerations on the design of lipid-based mRNA vaccines against cancer.

  2023cites this paper
• Design and Update of Multifunctional Polypeptides and Their Applications for the Prevention of Viral Infections and Cancer Immunotherapies

  2023cites this paper
• Humoral and Cellular Immunity Induced by Adjuvanted and Standard Trivalent Influenza Vaccine in Older Nursing Home Residents.

  2023cites this paper
• Two-dose “extended priming” immunization amplifies humoral immune responses by synchronizing vaccine delivery with the germinal center response

  2023cites this paper
• Exponentially decreasing exposure of antigen generates anti-inflammatory T-cell responses

  2023cites this paper
• Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases.

  2023cites this paper
• Chitosan particle-emulsion complex adjuvants: The effect of particle distribution on the immune intensity and response type.

  2023cites this paper
• Generation of antigen-specific memory CD4 T cells by heterologous immunization enhances the magnitude of the germinal center response upon influenza infection

  2023cites this paper
• The immune enhancement effect of CpG-ODNs on the vaccine of inactivated Vibrio harveyi in tiger puffer (Takifugu rubripes)

  2023cites this paper
• Human lymph node immune dynamics as driver of vaccine efficacy: an understudied aspect of immune responses

  2022cites this paper
• Nano alum: A new solution to the new challenge

  2022cites this paper
• ART duration and immunometabolic state determine efficacy of DC-based treatment restoring functional HIV- specific CD8+ T cells in Chronic PLWH

  2022cites this paper
• S100A4 exerts robust mucosal adjuvant activity for co-administered antigens in mice

  2022cites this paper
• A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice

  2022cites this paper
• Neutrophils recruited to immunization sites initiating vaccine-induced antibody responses by locally expressing BAFF

  2022cites this paper
• Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines

  2022cites this paper
• Innate immune mechanisms of mRNA vaccines

  2022cites this paper
• Investigating vaccine uptake dynamics of neutrophils using HIV-1 Envelope glycoprotein trimer

  2022influential citation
• Engineering optimal vaccination strategies: effects of physical properties of the delivery system on functions.

  2022cites this paper
• Development of therapeutic vaccines for the treatment of diseases

  2022cites this paper
• A novel built-in adjuvant metallothionein-3 aids protein antigens to induce rapid, robust, and durable immune responses

  2022cites this paper
• A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice

  2022cites this paper
• A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses

  2022cites this paper
• The lymphatic system and COVID-19 vaccines

  2022cites this paper
• Photoacoustic mediated multifunctional tumor antigen trapping nanoparticles inhibit the recurrence and metastasis of ovarian cancer by enhancing tumor immunogenicity

  2022cites this paper
• Optimization and use of near infrared imaging to guide lymph node collection in rhesus macaques (Macaca mulatta)

  2022cites this paper
• Intramuscular Inoculation of AS02-Adjuvanted Respiratory Syncytial Virus (RSV) F Subunit Vaccine Shows Better Efficiency and Safety Than Subcutaneous Inoculation in BALB/c Mice

  2022cites this paper
• Vaccine adjuvants to engage the cross-presentation pathway

  2022cites this paper
• Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans

  2022cites this paper
• Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

  2022influential citation
• Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV

  2022cites this paper
• α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants

  2021cites this paper
• B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat

  2021cites this paper
• Designing spatial and temporal control of vaccine responses

  2021cites this paper
• Broadly neutralizing antibodies target a haemagglutinin anchor epitope

  2021cites this paper
• T-follicular helper cells in malaria infection and roles in antibody induction

  2021cites this paper
• Dynamic regulation of innate lymphoid cells in the mucosal immune system

  2021influential citation
• Black phosphorous nanosheet: A novel immune-potentiating nanoadjuvant for near-infrared-improved immunotherapy.

  2021cites this paper
• Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response

  2021cites this paper
• The measurement and full statistical analysis including Bayesian methods of the aluminium content of infant vaccines.

  2021cites this paper
• Emerging concepts in the science of vaccine adjuvants

  2021cites this paper
• Squalene-Based Influenza Vaccine Adjuvants and Their Impact on the Hemagglutinin-Specific B Cell Response

  2021influential citation
• Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases

  2021cites this paper
• A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity

  2021cites this paper
• Recent trends in the development of Toll-like receptor 7/8-targeting therapeutics

  2021influential citation
• Transdermal Immunization of Elastic Liposome-Laden Recombinant Chimeric Fusion Protein of P. falciparum (PfMSP-Fu24) Mounts Protective Immune Response

  2021cites this paper
• Zwitterionic Phospholipidation of Cationic Polymers Facilitates Systemic mRNA Delivery to Spleen and Lymph Nodes.

  2021cites this paper
• Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction

  2021cites this paper
• Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans

  2021cites this paper